PDFF Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
<br />Notes are posted after they are approved by the PDFF BC during the following t-con | <br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on April 1, 2021. | ||
*[[Media:2021_02-04_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|February 4, 2021]] | *[[Media:2021_02-04_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|February 4, 2021]] | ||
Revision as of 18:52, 22 November 2021
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- RSNA Staff Support: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on April 1, 2021.
PDFF Biomarker Committee Call Summaries Archive